title: Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.
abstract: Human and porcine coagulation factor VIII (fVIII) display a biosynthetic efficiency differential that is being exploited for the development of new protein and gene transfer-based therapies for hemophilia A. The cellular and/or molecular mechanism(s) responsible for this phenomenon have yet to be uncovered, although it has been temporally localized to post-translational biosynthetic steps. The unfolded protein response (UPR) is a cellular adaptation to structurally distinct (e.g. misfolded) or excess protein in the endoplasmic reticulum and is known to be induced by heterologous expression of recombinant human fVIII. Therefore, it is plausible that the biosynthetic differential between human and porcine fVIII results from differential UPR activation. In the current study, UPR induction was examined in the context of ongoing fVIII expression. UPR activation was greater during human fVIII expression when compared with porcine fVIII expression as determined by ER response element (ERSE)-luciferase reporter activity, X-box-binding protein 1 (XBP1) splicing, and immunoglobulin-binding protein (BiP) up-regulation. Immunofluorescence microscopy of fVIII expressing cells revealed that human fVIII was notably absent in the Golgi apparatus, confirming that endoplasmic reticulum to Golgi transport is rate-limiting. In contrast, a significant proportion of porcine fVIII was localized to the Golgi indicating efficient transit through the secretory pathway. Overexpression of BiP, an integral UPR protein, reduced the secretion of human fVIII by 50%, but had no effect on porcine fVIII biosynthesis. In contrast, expression of BiP shRNA increased human fVIII expression levels. The current data support the model of differential engagement of UPR by human and porcine fVIII as a non-traditional mechanism for regulation of gene product biosynthesis.
authors: Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia 30322, USA.
authors: Harrison C
authors: HC
authors: Brown
authors: Bagirath
authors: B
authors: Gangadharan
authors: Christopher B
authors: CB
authors: Doering
references: Mol Ther. 2011 Feb;19(2):302-9
references: 21081907
references: Mol Ther. 2007 Jun;15(6):1093-9
references: 17387335
references: Blood. 2007 Oct 15;110(8):2855-63
references: 17569821
references: Thromb Haemost. 1998 May;79(5):932-7
references: 9609224
references: Nature. 1988 Mar 31;332(6163):462-4
references: 3352747
references: Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S3-14
references: 9607108
references: J Cell Biol. 1987 Dec;105(6 Pt 1):2665-74
references: 3121636
references: Haemophilia. 2010 Jul;16 Suppl 5:79-84
references: 20590861
references: J Biol Chem. 1997 Sep 26;272(39):24121-4
references: 9305856
references: J Biol Chem. 2002 Oct 11;277(41):38345-9
references: 12138172
references: Mol Ther. 2009 Jul;17(7):1145-54
references: 19259064
references: Nucleic Acids Res. 1999 Mar 15;27(6):1437-43
references: 10037803
references: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18525-30
references: 19011102
references: Nat Rev Mol Cell Biol. 2003 Mar;4(3):181-91
references: 12612637
references: J Biol Chem. 1989 Dec 5;264(34):20602-7
references: 2511206
references: J Biol Chem. 2004 Feb 20;279(8):6546-52
references: 14660593
references: Hum Gene Ther. 2009 May;20(5):465-78
references: 19222367
references: Blood. 2006 May 15;107(10):3859-64
references: 16449528
references: Mol Cell Biol. 2000 Jul;20(14):5096-106
references: 10866666
references: J Gene Med. 2010 Apr;12(4):333-44
references: 20209485
references: Thromb Haemost. 2002 Sep;88(3):450-8
references: 12353075
references: Expert Rev Hematol. 2009 Dec;2(6):673-683
references: 20577574
references: Semin Thromb Hemost. 2009 Jun;35(4):390-9
references: 19598067
references: Mol Cell Biol. 2006 Aug;26(15):5688-97
references: 16847323
references: Antioxid Redox Signal. 2007 Dec;9(12):2323-33
references: 17979529
references: Nat Rev Immunol. 2008 Sep;8(9):663-74
references: 18670423
references: J Clin Invest. 2001 May;107(10):1263-73
references: 11375416